MetaStat Inc (MTST)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:MetaStat Inc (MTST) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013337
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable targets. It offers products such as MetaSite Breast, an immunohistochemistry-based assay developed to predict the spread of cancer through the bloodstream to other organs; and MenaCalc Lung, a test evaluated to predict the likelihood of metastasis in adenocarcinoma of the lung. MetaStat also provides MenaCalc Prostate, a diagnostic for prostate cancer; and MenaBloc, a platform technology that develops therapies that can preemptively reduce or eliminate metastasis. Its technologies are based on identification of a pathway for developing metastatic disease in solid epithelial-based tumors. The company develops its products using mena protein, a potentiator and modulator of cellular migration. MetaStat is headquartered in Boston, Massachusetts, the US.

MetaStat Inc (MTST) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MetaStat Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
MetaStat Inc, Medical Devices Deals, 2011 to YTD 2017 9
MetaStat Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MetaStat Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 11
Licensing Agreements 12
ASET Therapeutics Enters into Licensing Agreement with MetaStat 12
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 14
Equity Offering 16
MetaStat Raises USD0.4 Million in Second Tranche of Private Placement of Shares and Preferred Shares 16
MetaStat Raises USD2.1 Million in First Tranche of Private Placement of Shares and Preferred Shares 17
MetaStat Raises USD2.1 Million in Final Tranche of Private Placement of Series B Preferred Shares 18
MetaStat Completes Private Placement Of Shares For US$0.81 Million 20
Acquisition 21
PhotoVoltaic Solar Cells Acquires MetaStat, Life Science Company 21
MetaStat Inc – Key Competitors 22
MetaStat Inc – Key Employees 23
MetaStat Inc – Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Corporate Communications 25
Aug 03, 2017: MetaStat Welcomes Renato T. Skerlj, Ph.D., Accomplished Drug Developer to Its Scientific and Clinical Advisory Board 25
May 08, 2017: MetaStat Elevates Jerome B. Zeldis, M.D., Ph.D. to Chairman of the Board and Appoints Douglas A. Hamilton, MetaStat’s President and CEO to its Board of Directors 26
Apr 27, 2016: MetaStat Appoints Jerome B. Zeldis, M.D., Ph.D. to its Board of Directors 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
MetaStat Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
MetaStat Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
MetaStat Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
MetaStat Inc, Deals By Therapy Area, 2011 to YTD 2017 8
MetaStat Inc, Medical Devices Deals, 2011 to YTD 2017 9
MetaStat Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 11
ASET Therapeutics Enters into Licensing Agreement with MetaStat 12
MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 14
MetaStat Raises USD0.4 Million in Second Tranche of Private Placement of Shares and Preferred Shares 16
MetaStat Raises USD2.1 Million in First Tranche of Private Placement of Shares and Preferred Shares 17
MetaStat Raises USD2.1 Million in Final Tranche of Private Placement of Series B Preferred Shares 18
MetaStat Completes Private Placement Of Shares For US$0.81 Million 20
PhotoVoltaic Solar Cells Acquires MetaStat, Life Science Company 21
MetaStat Inc, Key Competitors 22
MetaStat Inc, Key Employees 23

★海外企業調査レポート[MetaStat Inc (MTST)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Global Tungsten & Powders Corp.:企業の戦略・SWOT・財務情報
    Global Tungsten & Powders Corp. - Strategy, SWOT and Corporate Finance Report Summary Global Tungsten & Powders Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Attica Bank S.A.:企業の戦略・SWOT・財務情報
    Attica Bank S.A. - Strategy, SWOT and Corporate Finance Report Summary Attica Bank S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Pearson plc (PSON):企業の財務・戦略的SWOT分析
    Pearson plc (PSON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Kesoram Industries Ltd:企業の戦略・SWOT・財務情報
    Kesoram Industries Ltd - Strategy, SWOT and Corporate Finance Report Summary Kesoram Industries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • TRPHARM Ilac Sanayi Tic AS:製薬・医療:M&Aディール及び事業提携情報
    Summary TRPHARM Ilac Sanayi Tic AS (TRPharm) is a biopharmaceutical company focused on development and commercialization of novel innovative medicines for the treatment of oncology, neurology, inflammatory and rare diseases. The company conducts research and development programs and provide treatmen …
  • Curemark LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Curemark LLC (Curemark) is a biopharmaceutical company that develops novel therapies for the treatment of neurological disorders. The company’s pipeline products include CM-AT, CM-4612, CM-PK, CM-182, and CM-1212 drug candidates. Its drug candidate CM-AT is a clinical trial for autism, ADHD, …
  • Citibank NA:企業の戦略・SWOT・財務情報
    Citibank NA - Strategy, SWOT and Corporate Finance Report Summary Citibank NA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • CBRE Global Investors LLC:企業の戦略的SWOT分析
    CBRE Global Investors LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Murree Brewery Co. Ltd.
    Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Eastman Kodak Company:企業の戦略・SWOT・財務情報
    Eastman Kodak Company - Strategy, SWOT and Corporate Finance Report Summary Eastman Kodak Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Canon Medical Systems Corp:企業の戦略的SWOT分析
    Canon Medical Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Tata Motors Limited:企業の戦略・SWOT・財務情報
    Tata Motors Limited - Strategy, SWOT and Corporate Finance Report Summary Tata Motors Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • TIVIT Terceirizacao de Tecnologia e Servicos SA:企業の戦略的SWOT分析
    TIVIT Terceirizacao de Tecnologia e Servicos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • Corning Incorporated:企業のM&A・事業提携・投資動向
    Corning Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Corning Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Premaitha Health Plc (NIPT):医療機器:M&Aディール及び事業提携情報
    Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that a …
  • MYnd Analytics Inc (MYAN)-医療機器分野:企業M&A・提携分析
    Summary MYnd Analytics Inc (MYnd), formerly CNS Response Inc is a biotechnology company that offers medication development programs. The company performs analysis and research, and develops medication for individual patients suffering from mental health and other issues. It provides an PEER Online, …
  • Global Payments Inc.:企業の戦略・SWOT・財務分析
    Global Payments Inc. - Strategy, SWOT and Corporate Finance Report Summary Global Payments Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ACTIVE Network, LLC:企業のM&A・事業提携・投資動向
    ACTIVE Network, LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ACTIVE Network, LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Carbery Group:企業の戦略・SWOT・財務情報
    Carbery Group - Strategy, SWOT and Corporate Finance Report Summary Carbery Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Euronet Worldwide Inc (EEFT):企業の財務・戦略的SWOT分析
    Euronet Worldwide Inc (EEFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆